Skip to main content
XCUR
NASDAQ Life Sciences

Major Shareholder Exicure HiTron Inc. Reduces Stake in EXICURE, INC.

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$6.101
Mkt Cap
$38.884M
52W Low
$3.101
52W High
$15.91
52W Position info
97% above low
Off High info
62% below high
Rel. Volume
Market data snapshot near publication time

XCUR sits 97% above its 52-week low of $3.101.

Summary

Exicure HiTron Inc., a major shareholder, sold 258,367 shares of EXICURE, INC. common stock for $1.16 million, reducing its stake to 25.1%.


Key Events · Ownership and Investor Activity · XCUR

  • Significant Share Transfer

    Exicure HiTron Inc. transferred 258,367 shares of EXICURE, INC. common stock.

  • Transaction Value

    The shares were transferred at $4.50 per share, totaling approximately $1.16 million.

  • Reduced Ownership Stake

    Following the transfer, Exicure HiTron Inc.'s beneficial ownership decreased to 1,598,947 shares, representing 25.1% of the outstanding common stock.

  • Stated Purpose

    The filer indicated the shares were transferred for liquidity purposes.


Analysis · XCUR · Life Sciences

Exicure HiTron Inc., a significant shareholder, completed the transfer of 258,367 shares of common stock for approximately $1.16 million. This transaction reduces their beneficial ownership to 25.1% of the outstanding shares. While the filer states the transfer was for liquidity purposes, a substantial sale by a major investor can be perceived negatively by the market, indicating a potential lack of conviction or a need for capital elsewhere.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, XCUR was trading at $6.10 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $38.9M. The 52-week trading range was $3.10 to $15.91. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

XCUR - Latest Insights

XCUR
Nov 20, 2026, 5:13 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.9001
Real-time Price: $0.9905 info
Change: +$0.0904 (+10%) info
Market Cap: $5.892M info
XCUR
Nov 20, 2026, 1:00 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.920
Real-time Price: $0.9905 info
Change: +$0.0705 (+8%) info
Market Cap: $5.892M info
XCUR
Nov 16, 2026, 4:00 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.07
Real-time Price: $0.9905 info
Change: -$0.0795 (-7%) info
Market Cap: $5.892M info
XCUR
Nov 10, 2026, 3:50 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.08
Real-time Price: $0.9905 info
Change: -$0.0905 (-8%) info
Market Cap: $5.892M info
XCUR
Nov 10, 2026, 3:50 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.08
Real-time Price: $0.9905 info
Change: -$0.0905 (-8%) info
Market Cap: $5.892M info